Register      Login
Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
RESEARCH ARTICLE

Cervicitis: limited clinical utility for the detection of Mycoplasma genitalium in a cross-sectional study of women attending a New Zealand sexual health clinic

Jeannie Oliphant A B and Sunita Azariah A
+ Author Affiliations
- Author Affiliations

A Auckland Sexual Health Service, Greenlane Clinical Centre, Private Bag 92024, Auckland 1142, New Zealand.

B Corresponding author. Email: jeannieo@adhb.govt.nz

Sexual Health 10(3) 263-267 https://doi.org/10.1071/SH12168
Submitted: 9 October 2012  Accepted: 8 February 2013   Published: 24 May 2013

Abstract

Background: Although multiple studies have confirmed Mycoplasma genitalium as a cause of nongonococcal urethritis in men, there is less evidence of its pathogenicity in women. Our aims were to determine the prevalence of M. genitalium in a sample of women attending a sexual health clinic and to assess whether there was any association between the detection of M. genitalium and a diagnosis of cervicitis in this population. Methods: A cross-sectional study recruited women who required screening for sexually transmissible infections. Endocervical swabs to detect the presence of M. genitalium were taken in addition to routine testing for Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis. Data were collected on demographics, sexual behaviour, clinical symptoms and the presence of clinical or microscopic cervicitis. Results: The prevalence of M. genitalium was 8.4% (n = 22, 95% confidence interval (CI): 5.4–12.5%) in the study sample of 261 women. There was an association between the finding of cervical contact bleeding (odds ratio OR): 5.45; 95% CI: 1.93–15.42, P = 0.001) and microscopic cervicitis (OR: 2.64; 95% CI: 0.95–7.34, P = 0.06) and the presence of M. genitalium when compared with women with no diagnosed infection; however, the latter finding was not statistically significant. Conclusions: Although the prevalence of M. genitalium was high at 8.4%, the overall lack of any association between the findings of cervicitis and the detection of M. genitalium support the conclusion that cervicitis has poor clinical utility as an indicator for the presence of M. genitalium infection.

Additional keywords: cervical contact bleeding, sexually transmissible infections, testing.


References

[1]  Tully JG, Taylor-Robinson D, Cole RM, Rose DL. A newly discovered mycoplasma in the human urogenital tract. Lancet 1981; 317 1288–91.
A newly discovered mycoplasma in the human urogenital tract.Crossref | GoogleScholarGoogle Scholar |

[2]  Falk L, Fredlund H, Jensen JS. Symptomatic urethritis is more prevalent in men infected with Mycoplasma genitalium than with Chlamydia trachomatis. Sex Transm Infect 2004; 80 289–93.
Symptomatic urethritis is more prevalent in men infected with Mycoplasma genitalium than with Chlamydia trachomatis.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2czptFOqsA%3D%3D&md5=dbeda1f3ad8d82f66662c9baba5e0100CAS | 15295128PubMed |

[3]  Leung A, Eastick K, Haddon LE, Horn CK, Ahuja D, Horner PJ. Mycoplasma genitalium is associated with symptomatic urethritis. Int J STD AIDS 2006; 17 285–8.
Mycoplasma genitalium is associated with symptomatic urethritis.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD283jsleisw%3D%3D&md5=a35f28a2d1a391473df1302a41215a9eCAS | 16643675PubMed |

[4]  Anagrius C, Loré B, Jensen JS. Mycoplasma genitalium: prevalence, clinical significance, and transmission. Sex Transm Infect 2005; 81 458–62.
Mycoplasma genitalium: prevalence, clinical significance, and transmission.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2MnksleitA%3D%3D&md5=897c8f791f46abd3b28749fa12a62020CAS | 16326846PubMed |

[5]  Lusk MJ, Konecny P, Naing ZW, Garden FL, Cumming RG, Rawlinson WD. Mycoplasma genitalium is associated with cervicitis and HIV infection in an urban Australian STI clinic population. Sex Transm Infect 2011; 87 107–9.
Mycoplasma genitalium is associated with cervicitis and HIV infection in an urban Australian STI clinic population.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC3M3gs1Cksg%3D%3D&md5=59d66c02fa4b16beb69cb9b5eec4a5a9CAS | 21071566PubMed |

[6]  Moi H, Reinton N, Moghaddam A. Mycoplasma genitalium in women with lower genital tract inflammation. Sex Transm Infect 2009; 85 10–4.
Mycoplasma genitalium in women with lower genital tract inflammation.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD1M%2Fos12hsg%3D%3D&md5=b884fa99c496f16c8b9244a2f305987aCAS | 18842689PubMed |

[7]  Manhart LE, Mostad SB, Baeten JM, Astete SG, Mandaliya K, Totten PA. High Mycoplasma genitalium organism burden is associated with shedding of HIV-1 DNA from the cervix. J Infect Dis 2008; 197 733–6.
High Mycoplasma genitalium organism burden is associated with shedding of HIV-1 DNA from the cervix.Crossref | GoogleScholarGoogle Scholar | 18266605PubMed |

[8]  Högdahl M, Kihlstrom E. Leucocyte esterase testing of first-voided urine and urethral and cervical smears to identify Mycoplasma genitalium-infected men and women. Int J STD AIDS 2007; 18 835–8.
Leucocyte esterase testing of first-voided urine and urethral and cervical smears to identify Mycoplasma genitalium-infected men and women.Crossref | GoogleScholarGoogle Scholar | 18073017PubMed |

[9]  Manhart LE, Critchlow CW, Holmes KK, Dutro SM, Eschenbach DA, Stevens CE, et al Mucopurulent cervicitis and Mycoplasma genitalium. J Infect Dis 2003; 187 650–7.
Mucopurulent cervicitis and Mycoplasma genitalium.Crossref | GoogleScholarGoogle Scholar | 12599082PubMed |

[10]  Pépin J, Labbé A-C, Khonde N, Deslandes S, Alary M, Dzokoto A, et al Mycoplasma genitalium: an organism commonly associated with cervicitis among west African sex workers. Sex Transm Infect 2005; 81 67–72.
Mycoplasma genitalium: an organism commonly associated with cervicitis among west African sex workers.Crossref | GoogleScholarGoogle Scholar | 15681727PubMed |

[11]  Casin I, Vexiau-Robert D, De la Salmonière P, Eche A, Grandry B, Janier M. High prevalence of Mycoplasma genitalium in the lower genitourinary tract of women attending a sexually transmitted disease clinic in Paris, France. Sex Transm Dis 2002; 29 353–9.
High prevalence of Mycoplasma genitalium in the lower genitourinary tract of women attending a sexually transmitted disease clinic in Paris, France.Crossref | GoogleScholarGoogle Scholar | 12035026PubMed |

[12]  Korte JE, Baseman JB, Cagle MP, Herrera C, Piper JM, Holden AEC, et al Cervicitis and genitourinary symptoms in women culture positive for Mycoplasma genitalium. Am J Reprod Immunol 2006; 55 265–75.
Cervicitis and genitourinary symptoms in women culture positive for Mycoplasma genitalium.Crossref | GoogleScholarGoogle Scholar | 16533338PubMed |

[13]  Cohen CR, Nosek M, Meier A, Astete SG, Iverson-Caral S, Mugo NR, et al Mycoplasma genitalium infection and persistence in a cohort of female sex workers in Nairobi, Kenya. Sex Transm Dis 2007; 34 274–9.
| 16940898PubMed |

[14]  Huppert JS, Mortensen JE, Reed JL, Kahn JA, Rich KD, Hobbs MM. Mycoplasma genitalium detected by transcription-mediated amplification is associated with Chlamydia trachomatis in adolescent women. Sex Transm Dis 2008; 35 250–4.
Mycoplasma genitalium detected by transcription-mediated amplification is associated with Chlamydia trachomatis in adolescent women.Crossref | GoogleScholarGoogle Scholar | 18490867PubMed |

[15]  Simms I, Eastick K, Mallinson H, Thomas K, Gokhale R, Hay P, et al Associations between Mycoplasma genitalium, Chlamydia trachomatis, and pelvic inflammatory disease. Sex Transm Infect 2003; 79 154–6.
Associations between Mycoplasma genitalium, Chlamydia trachomatis, and pelvic inflammatory disease.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3s7ntFyksg%3D%3D&md5=bde659835b0a304c1c6c158f679837a7CAS | 12690141PubMed |

[16]  Haggerty CL, Totten PA, Astete SG, Ness RB. Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease. Infect Dis Obstet Gynecol 2006; 2006 30184
Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease.Crossref | GoogleScholarGoogle Scholar | 17485798PubMed |

[17]  Bjartling C, Osser S, Persson K. The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy. BJOG 2010; 117 361–4.
The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3cXitFGisr8%3D&md5=25d918c3a76280c9582abc7cfa2b0158CAS | 20015303PubMed |

[18]  Oakeshott P, Aghaizu A, Hay P, Reid F, Kerry S, Atherton H, et al Is Mycoplasma genitalium in women the “new chlamydia?” A community-based prospective cohort study. Clin Infect Dis 2010; 51 1160–6.
Is Mycoplasma genitalium in women the “new chlamydia?” A community-based prospective cohort study.Crossref | GoogleScholarGoogle Scholar | 20942656PubMed |

[19]  Hilton J, Azariah S, Reid M. A case–control study of men with non-gonococcal urethritis at Auckland Sexual Health Service: rates of detection of Mycoplasma genitalium. Sex Health 2010; 7 77–81.
A case–control study of men with non-gonococcal urethritis at Auckland Sexual Health Service: rates of detection of Mycoplasma genitalium.Crossref | GoogleScholarGoogle Scholar | 20152101PubMed |

[20]  Lawton BA, Rose SB, Bromhead C, Gaitanos LA, MacDonald EJ, Lund KA. High prevalence of Mycoplasma genitalium in women presenting for termination of pregnancy. Contraception 2008; 77 294–8.
High prevalence of Mycoplasma genitalium in women presenting for termination of pregnancy.Crossref | GoogleScholarGoogle Scholar | 18342654PubMed |

[21]  Tabrizi SN, Chen S, Cohenford MA, Lentrichia BB, Coffman E, Shultz T, et al Evaluation of real time polymerase chain reaction assays for confirmation of Neisseria gonorrhoeae in clinical samples tested positive in the Roche Cobas Amplicor assay. Sex Transm Infect 2004; 80 68–71.
Evaluation of real time polymerase chain reaction assays for confirmation of Neisseria gonorrhoeae in clinical samples tested positive in the Roche Cobas Amplicor assay.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2c%2FotFOguw%3D%3D&md5=bd894e67e64492a300a73717d5a26558CAS | 14755041PubMed |

[22]  Twin J, Taylor N, Garland SM, Hocking JS, Walker J, Bradshaw CS, et al Comparison of two Mycoplasma genitalium real-time PCR detection methodologies. J Clin Microbiol 2011; 49 1140–2.
Comparison of two Mycoplasma genitalium real-time PCR detection methodologies.Crossref | GoogleScholarGoogle Scholar | 21209170PubMed |

[23]  Rahman S, Garland S, Currie M, Tabrizi SN, Rahman M, Nessa K, et al Prevalence of Mycoplasma genitalium in health clinic attendees complaining of vaginal discharge in Bangladesh. Int J STD AIDS 2008; 19 772–4.
Prevalence of Mycoplasma genitalium in health clinic attendees complaining of vaginal discharge in Bangladesh.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD1cnnt1yluw%3D%3D&md5=60efece06cfb7835cb150350443851e0CAS | 18931272PubMed |

[24]  Tosh AK, Van Der Pol B, Fortenberry JD, Williams JA, Katz BP, Batteiger BE, et al Mycoplasma genitalium among adolescent women and their partners. J Adolesc Health 2007; 40 412–7.
Mycoplasma genitalium among adolescent women and their partners.Crossref | GoogleScholarGoogle Scholar | 17448398PubMed |

[25]  McIver CJ, Rismanto N, Smith C, Naing ZW, Rayner B, Lusk MJ, et al Multiplex PCR testing detection of higher-than-expected rates of cervical Mycoplasma, ureaplasma and trichomonas and viral agent infections in sexually active Australia women. J Clin Microbiol 2009; 47 1358–63.
Multiplex PCR testing detection of higher-than-expected rates of cervical Mycoplasma, ureaplasma and trichomonas and viral agent infections in sexually active Australia women.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1MXmt1Cqsr0%3D&md5=6ce7dcf8305b39ac9da8719c0582764dCAS | 19261782PubMed |

[26]  Ross JD, Brown L, Saunders P, Alexander S. Mycoplasma genitalium in asymptomatic patients: implications for screening. Sex Transm Infect 2009; 85 436–7.
Mycoplasma genitalium in asymptomatic patients: implications for screening.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD1MnoslSntQ%3D%3D&md5=14cdffce2e990d4a7d7bcace8bbec725CAS | 19587392PubMed |

[27]  Gaydos C, Maldeis NE, Hardick A, Hardick J, Quinn TC. Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics. Sex Transm Dis 2009; 36 606
Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics.Crossref | GoogleScholarGoogle Scholar | 19704398PubMed |

[28]  McGowin CL, Anderson-Smits C. Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women. PLoS Pathog 2011; 7 e1001324
Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXntVajsrs%3D&md5=8e105c4ec9aa09e8a65fae3f6dc7b16bCAS | 21637847PubMed |

[29]  Weinstein SA, Stiles BG. A review of the epidemiology, diagnosis and evidence-based management of Mycoplasma genitalium. Sex Health 2011; 8 143–58.
A review of the epidemiology, diagnosis and evidence-based management of Mycoplasma genitalium.Crossref | GoogleScholarGoogle Scholar | 21592428PubMed |

[30]  Judlin P. Current concepts in managing pelvic inflammatory disease. Curr Opin Infect Dis 2010; 23 83–7.
Current concepts in managing pelvic inflammatory disease.Crossref | GoogleScholarGoogle Scholar | 19935421PubMed |